PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19190824-2 2009 In the present research approach, our objective was to investigate the possible alterations in the mRNA expression levels of KLK5 and KLK11 genes in prostate cancer cells PC3 as a response to treatment with mitoxantrone, etoposide, doxorubicin and carboplatin. Doxorubicin 232-243 kallikrein related peptidase 11 Homo sapiens 134-139